ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BMTX1Y45
Stock Name / FundiShares S&P 500 Swap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerI500.AS(USD) CXE
ETF TickerI500.DE(EUR) CXE
ETF TickerI500.LS(GBP) CXE
ETF TickerI500(EUR) ETF Plus

Holdings detail for ALNY

Stock NameAlnylam Pharmaceuticals Inc
TickerALNY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS02043Q1076
LEI529900S3ZI14OWRJII50

Show aggregate ALNY holdings

News associated with ALNY

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $500.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by Royal Bank Of Canada from $435.00 to $500.00 in a report issued on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other reports. The Goldman Sachs Group boosted their price […] - 2025-09-22 02:32:43
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $520.00 Price Target at Bank of America
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective raised by Bank of America from $453.00 to $520.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on ALNY. Oppenheimer upgraded shares […] - 2025-09-18 04:26:54
The Goldman Sachs Group Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by The Goldman Sachs Group from $504.00 to $566.00 in a report published on Tuesday,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Chardan Capital lifted […] - 2025-09-17 03:14:44
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $421.28
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-seven analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and twenty-three have issued a buy recommendation on the company. The average 1 year target price […] - 2025-09-15 02:47:58
Alnylam Announces Pricing Of Upsized Offering Of $575 Mln Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced the pricing of its private offering of $575 million aggregate principal amount of 0.00% convertible senior notes due 2028. The size of the offering was increased from the previously announced offering of $500 million aggre - 2025-09-10 00:33:28
Alnylam Pharma Commences Private Offering Of $500 Mln Of Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced that it has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028. In connection with this offering, Alnylam expects to grant the initial purchasers of the notes an op - 2025-09-09 00:30:30
ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win
Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study. - 2025-09-01 11:50:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Dennis A. Ausiello Sells 31,448 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Dennis A. Ausiello sold 31,448 shares of the company’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $436.58, for a total value of $13,729,567.84. Following the completion of the sale, the director directly owned 911 shares in […] - 2025-08-18 05:14:55
LPL Financial LLC Buys 2,107 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
LPL Financial LLC grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,679 shares of the biopharmaceutical company’s stock after acquiring an additional 2,107 shares during the period. LPL Financial LLC’s holdings […] - 2025-08-13 05:04:56
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Cetera Investment Advisers Has $2.17 Million Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Cetera Investment Advisers raised its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 68.1% during the first quarter, Holdings Channel reports. The firm owned 8,017 shares of the biopharmaceutical company’s stock after purchasing an additional 3,247 shares during the period. Cetera Investment Advisers’ holdings in Alnylam Pharmaceuticals were worth $2,165,000 at the end […] - 2025-08-08 04:44:59
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded at Oppenheimer
Oppenheimer upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Monday, Marketbeat.com reports. The brokerage currently has $490.00 target price on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. Barclays lifted their price […] - 2025-08-07 02:54:47
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded by Wolfe Research to Peer Perform Rating
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating in a research report issued on Monday, Marketbeat reports. A number of other brokerages have also recently issued reports on ALNY. Canaccord Genuity Group lifted their price target on shares […] - 2025-08-06 03:02:54
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $400.00 at Chardan Capital
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Chardan Capital from $325.00 to $400.00 in a research report report published on Friday,Benzinga reports. Chardan Capital currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on ALNY. Needham & Company LLC raised their […] - 2025-08-04 02:48:47
Needham & Company LLC Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $478.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target hoisted by Needham & Company LLC from $377.00 to $478.00 in a research report report published on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on the […] - 2025-08-03 05:28:56
Noteworthy ETF Outflows: XBI, MRNA, ALNY, EXEL
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $225.3 million dollar outflow -- that's a 4.6% decrease week over week - 2025-07-30 11:49:03
Y Intercept Hong Kong Ltd Has $1 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Y Intercept Hong Kong Ltd lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 17.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,720 shares of the biopharmaceutical company’s stock after selling 796 shares during the period. […] - 2025-07-25 06:12:53
Victory Capital Management Inc. Cuts Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Victory Capital Management Inc. lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,649 shares of the biopharmaceutical company’s stock after selling 2,148 shares during the period. Victory Capital […] - 2025-07-25 05:14:50
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-six research firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and twenty-two have assigned a buy recommendation to the […] - 2025-07-24 06:26:55
Alnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Truist Financial
Truist Financial initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $385.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts also recently issued reports on ALNY. Jefferies Financial […] - 2025-07-22 03:14:59
Nisa Investment Advisors LLC Cuts Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Nisa Investment Advisors LLC cut its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 38.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,155 shares of the biopharmaceutical company’s stock after selling 5,162 shares during […] - 2025-07-14 05:54:56
Crossmark Global Holdings Inc. Takes Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Crossmark Global Holdings Inc. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,018 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Other hedge funds have also modified their holdings of the […] - 2025-07-14 05:14:48
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. decreased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,691 shares of the biopharmaceutical company’s stock after selling 113 shares during the […] - 2025-07-08 04:40:51
Mirae Asset Global Investments Co. Ltd. Sells 2,596 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Mirae Asset Global Investments Co. Ltd. reduced its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 28.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,534 shares of the biopharmaceutical company’s stock after selling 2,596 shares during the […] - 2025-07-04 04:52:27
Wells Fargo & Company Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $333.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target lifted by research analysts at Wells Fargo & Company from $287.00 to $333.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside […] - 2025-07-02 03:05:01
Diversified Trust Co Sells 999 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Diversified Trust Co cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 40.3% in the first quarter, Holdings Channel reports. The institutional investor owned 1,482 shares of the biopharmaceutical company’s stock after selling 999 shares during the period. Diversified Trust Co’s holdings in Alnylam Pharmaceuticals were worth $400,000 as of […] - 2025-07-01 07:10:56
Sequoia Financial Advisors LLC Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Sequoia Financial Advisors LLC lifted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 3.0% in the first quarter, HoldingsChannel reports. The fund owned 3,395 shares of the biopharmaceutical company’s stock after acquiring an additional 99 shares during the period. Sequoia Financial Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $917,000 […] - 2025-07-01 05:22:50
Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 12-Month High Following Analyst Upgrade
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) hit a new 52-week high on Monday after Wells Fargo & Company raised their price target on the stock from $287.00 to $333.00. Wells Fargo & Company currently has an equal weight rating on the stock. Alnylam Pharmaceuticals traded as high as $327.05 and last […] - 2025-07-01 02:27:01
Kentucky Retirement Systems Buys New Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Kentucky Retirement Systems bought a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,794 shares of the biopharmaceutical company’s stock, valued at approximately $2,375,000. Several other institutional investors and […] - 2025-06-24 06:20:52

iShares S&P 500 Swap UCITS ETF USD (Acc) ALNY holdings

DateNumber of ALNY Shares HeldBase Market Value of ALNY SharesLocal Market Value of ALNY SharesChange in ALNY Shares HeldChange in ALNY Base ValueCurrent Price per ALNY Share HeldPrevious Price per ALNY Share Held
2026-02-09 (Monday)63,832USD 20,426,240USD 20,426,240
2026-02-09 (Monday)-63,832USD -20,426,240USD -20,426,240
2026-02-06 (Friday)63,832ALNY holding decreased by -127664USD 20,947,109ALNY holding decreased by -41894218USD 20,947,109-127,664USD -41,894,218 USD 130.74 USD 129.71
2026-02-06 (Friday)-63,832ALNY holding decreased by -127664USD -20,947,109ALNY holding decreased by -41894218USD -20,947,109-127,664USD -41,894,218 USD 130.74 USD 129.71
2026-02-02 (Monday)63,832ALNY holding increased by 127664USD 21,646,070ALNY holding increased by 43225116USD 21,646,070127,664USD 43,225,116 USD 339.11 USD 0
2026-02-02 (Monday)-63,832ALNY holding increased by 127664USD -21,646,070ALNY holding increased by 43225116USD -21,646,070127,664USD 43,225,116 USD 339.11 USD 0
2026-01-30 (Friday)63,832ALNY holding increased by 127664USD 21,579,046ALNY holding increased by 43715345USD 21,579,046127,664USD 43,715,345 USD 338.06 USD 0
2026-01-30 (Friday)-63,832ALNY holding increased by 127664USD -21,579,046ALNY holding increased by 43715345USD -21,579,046127,664USD 43,715,345 USD 338.06 USD 0
2026-01-29 (Thursday)63,832ALNY holding increased by 127664USD 22,136,299ALNY holding increased by 44450690USD 22,136,299127,664USD 44,450,690 USD 346.79 USD 0
2026-01-29 (Thursday)-63,832ALNY holding increased by 127664USD -22,136,299ALNY holding increased by 44450690USD -22,136,299127,664USD 44,450,690 USD 346.79 USD 0
2026-01-28 (Wednesday)63,832ALNY holding increased by 127664USD 22,314,391ALNY holding increased by 44958793USD 22,314,391127,664USD 44,958,793 USD 349.58 USD 0
2026-01-28 (Wednesday)-63,832ALNY holding increased by 127664USD -22,314,391ALNY holding increased by 44958793USD -22,314,391127,664USD 44,958,793 USD 349.58 USD 0
2026-01-27 (Tuesday)63,832ALNY holding increased by 127664USD 22,644,402ALNY holding increased by 45710095USD 22,644,402127,664USD 45,710,095 USD 354.75 USD 0
2026-01-27 (Tuesday)-63,832ALNY holding increased by 127664USD -22,644,402ALNY holding increased by 45710095USD -22,644,402127,664USD 45,710,095 USD 354.75 USD 0
2026-01-26 (Monday)63,832ALNY holding increased by 127664USD 23,065,693ALNY holding increased by 45916272USD 23,065,693127,664USD 45,916,272 USD 361.35 USD 0
2026-01-26 (Monday)-63,832ALNY holding increased by 127664USD -23,065,693ALNY holding increased by 45916272USD -23,065,693127,664USD 45,916,272 USD 361.35 USD 0
2026-01-23 (Friday)63,832ALNY holding increased by 127664USD 22,850,579ALNY holding increased by 46468419USD 22,850,579127,664USD 46,468,419 USD 357.98 USD 0
2026-01-23 (Friday)-63,832ALNY holding increased by 127664USD -22,850,579ALNY holding increased by 46468419USD -22,850,579127,664USD 46,468,419 USD 357.98 USD 0
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALNY by Blackrock for IE00BMTX1Y45

Show aggregate share trades of ALNY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06SELL-127,664 130.740* -
2026-02-02BUY127,664342.240333.010 333.933USD 42,631,224 -
2026-01-30BUY127,664346.010336.390 337.352USD 43,067,708 -
2026-01-29BUY127,664350.340345.010 345.543USD 44,113,403 -
2026-01-28BUY127,664356.840348.000 348.884USD 44,539,927 -
2026-01-27BUY127,664368.070354.690 356.028USD 45,451,959 -
2026-01-26BUY127,664364.070352.500 353.657USD 45,149,267 -
2026-01-23BUY127,664371.330356.790 358.244USD 45,734,863 -
2026-01-22BUY127,664376.870363.360 364.711USD 46,560,463 -
2026-01-21BUY127,664366.000351.550 352.995USD 45,064,752 -
2026-01-20BUY127,664355.740347.860 348.648USD 44,509,796 -
2026-01-19BUY127,664 359.270* -
2026-01-16BUY127,664367.200355.460 356.634USD 45,529,322 -
2026-01-15BUY127,664372.820356.840 358.438USD 45,759,629 -
2026-01-14BUY127,664371.600359.950 361.115USD 46,101,387 -
2026-01-13BUY127,664376.880366.920 367.916USD 46,969,630 -
2026-01-12BUY127,664378.605353.520 356.028USD 45,452,021 -
2026-01-09BUY127,664409.480392.560 394.252USD 50,331,787 -
2026-01-08BUY127,664425.190393.480 396.651USD 50,638,055 -
2026-01-07BUY127,148427.050405.510 407.664USD 51,833,663 -
2026-01-06SELL-126,632399.000393.720 394.248USD -49,924,413 -
2025-12-15BUY6,232402.330390.050 391.278USD 2,438,444 -
2025-12-12BUY6,232410.040387.030 389.331USD 2,426,311 -
2025-12-11BUY6,232414.220402.220 403.420USD 2,514,113 -
2025-12-10BUY6,232416.970403.805 405.121USD 2,524,717 -
2025-12-09BUY45,452433.305414.450 416.336USD 18,923,282 -
2025-12-08BUY84,672449.780423.450 426.083USD 36,077,301 -
2025-12-05BUY84,672473.500455.320 457.138USD 38,706,789 -
2025-12-04SELL-84,672476.810463.030 464.408USD -39,322,354 -
2025-11-20BUY33,378467.730445.340 447.579USD 14,939,292 -
2025-11-19BUY33,378465.320456.900 457.742USD 15,278,512 -
2025-11-18BUY33,378469.110456.270 457.554USD 15,272,237 -
2025-11-17BUY33,378463.750449.000 450.475USD 15,035,955 -
2025-11-14BUY33,378461.960448.280 449.648USD 15,008,351 -
2025-11-13BUY33,378456.140447.155 448.054USD 14,955,130 -
2025-11-12BUY33,378459.270447.130 448.344USD 14,964,826 -
2025-11-11BUY33,378455.200441.210 442.609USD 14,773,403 -
2025-11-10BUY33,378449.680440.930 441.805USD 14,746,567 -
2025-11-07BUY33,378443.587430.835 432.110USD 14,422,976 -
2025-11-06BUY33,378445.490429.000 430.649USD 14,374,202 -
2025-11-05BUY33,378438.530417.000 419.153USD 13,990,489 -
2025-11-04BUY33,378431.500421.830 422.797USD 14,112,118 -
2025-11-03BUY33,378457.260429.615 432.379USD 14,431,963 -
2025-10-31BUY33,378459.570441.220 443.055USD 14,788,290 -
2025-10-30BUY27,656471.980436.512 440.059USD 12,170,264 -
2025-10-29BUY21,934481.590482.730 482.616USD 10,585,697 -
2025-10-28BUY21,934475.910484.610 483.740USD 10,610,353 -
2025-10-27BUY21,934478.580485.360 484.682USD 10,631,015 -
2025-10-24BUY21,934463.430469.290 468.704USD 10,280,554 -
2025-10-23BUY21,934464.000468.860 468.374USD 10,273,315 -
2025-10-22BUY21,934464.900480.530 478.967USD 10,505,662 -
2025-10-21BUY21,934474.000490.050 488.445USD 10,713,552 -
2025-10-20BUY21,934491.220495.550 495.117USD 10,859,896 -
2025-10-17BUY21,934481.670492.620 491.525USD 10,781,109 -
2025-10-16BUY21,934481.070488.390 487.658USD 10,696,291 -
2025-10-15BUY21,934470.270485.280 483.779USD 10,611,209 -
2025-10-14BUY21,934469.360479.690 478.657USD 10,498,863 -
2025-10-13SELL-21,934464.950473.650 472.780USD -10,369,956 -
2025-10-08BUY21,934450.680464.460 463.082USD 10,157,240 -
2025-10-07BUY21,934459.580462.630 462.325USD 10,140,637 -
2025-10-06BUY21,934452.000458.690 458.021USD 10,046,233 -
2025-10-03BUY21,934456.350465.010 464.144USD 10,180,535 -
2025-10-02BUY21,934460.990461.530 461.476USD 10,122,015 -
2025-10-01BUY21,934460.650467.420 466.743USD 10,237,541 -
2025-09-30BUY21,934456.000459.300 458.970USD 10,067,048 -
2025-09-29BUY21,934447.490451.630 451.216USD 9,896,972 -
2025-09-26BUY21,934446.400453.050 452.385USD 9,922,612 -
2025-09-25BUY21,934449.580459.000 458.058USD 10,047,044 -
2025-09-24SELL-21,934458.370462.690 462.258USD -10,139,167 -
2025-09-18BUY21,934452.170456.940 456.463USD 10,012,060 -
2025-09-17BUY21,934451.730463.880 462.665USD 10,148,094 -
2025-09-16BUY21,934461.240467.280 466.676USD 10,236,071 -
2025-09-15BUY21,934461.140466.240 465.730USD 10,215,322 -
2025-09-12BUY21,934465.890475.690 474.710USD 10,412,289 -
2025-09-11BUY21,934468.580474.340 473.764USD 10,391,539 -
2025-09-10BUY21,934469.310480.050 478.976USD 10,505,859 -
2025-09-09BUY21,934482.130484.210 484.002USD 10,616,100 -
2025-09-08SELL-21,934455.030463.000 462.203USD -10,137,961 -
2025-09-05BUY21,934452.000455.280 454.952USD 9,978,917 -
2025-09-04BUY21,934453.540458.300 457.824USD 10,041,911 -
2025-09-02BUY21,934447.000454.500 453.750USD 9,952,553 -
2025-08-29BUY21,934446.510453.960 453.215USD 9,940,818 -
2025-08-28BUY21,934452.330457.290 456.794USD 10,019,320 -
2025-08-27BUY21,934454.180455.450 455.323USD 9,987,055 -
2025-08-25BUY22,728443.640458.750 457.239USD 10,392,128 -
2025-08-22BUY23,522454.380469.810 468.267USD 11,014,576 -
2025-08-21BUY23,522467.550467.710 467.694USD 11,001,098 -
2025-08-20BUY23,522458.310466.310 465.510USD 10,949,726 -
2025-08-19BUY23,522458.280462.880 462.420USD 10,877,043 -
2025-08-18BUY23,522456.870457.920 457.815USD 10,768,725 -
2025-08-15BUY23,522448.910449.520 449.459USD 10,572,174 -
2025-08-13BUY23,522432.520438.230 437.659USD 10,294,615 -
2025-08-12BUY23,522429.930437.000 436.293USD 10,262,484 -
2025-08-11BUY23,522435.000445.200 444.180USD 10,448,002 -
2025-08-08BUY23,522438.930439.360 439.317USD 10,333,614 -
2025-08-07BUY23,522435.100436.770 436.603USD 10,269,776 -
2025-08-06BUY23,522428.140428.690 428.635USD 10,082,353 -
2025-08-05BUY23,522418.910426.760 425.975USD 10,019,784 -
2025-08-04BUY23,522419.560422.640 422.332USD 9,934,094 -
2025-08-01BUY23,522401.800401.800 401.800USD 9,451,139 -
2025-07-31BUY23,522392.240402.430 401.411USD 9,441,989 -
2025-07-30BUY23,522339.800345.980 345.362USD 8,123,605 -
2025-07-29BUY23,522330.550331.060 331.009USD 7,785,994 -
2025-07-28BUY23,522324.790331.430 330.766USD 7,780,278 -
2025-07-25BUY23,522328.810331.500 331.231USD 7,791,216 -
2025-07-24BUY23,522328.000332.190 331.771USD 7,803,918 -
2025-07-23BUY23,522325.640329.340 328.970USD 7,738,032 -
2025-07-22BUY23,522325.280326.300 326.198USD 7,672,829 -
2025-07-21SELL-23,522320.520328.700 327.882USD -7,712,441 -
2025-07-18BUY23,522320.530325.620 325.111USD 7,647,261 -
2025-07-17BUY23,522324.690329.870 329.352USD 7,747,018 -
2025-07-16BUY23,522322.810323.410 323.350USD 7,605,839 -
2025-07-15BUY23,522311.120316.900 316.322USD 7,440,526 -
2025-07-14BUY23,522315.750319.180 318.837USD 7,499,684 -
2025-07-11BUY23,522314.940321.120 320.502USD 7,538,848 -
2025-07-10BUY23,522322.640324.820 324.602USD 7,635,288 -
2025-07-09BUY23,522320.870322.680 322.499USD 7,585,821 -
2025-07-08BUY23,522317.500328.990 327.841USD 7,711,476 -
2025-07-07BUY25,468324.130328.240 327.829USD 8,349,149 -
2025-07-04SELL-27,414 373.300* -
2025-07-03BUY27,414331.910333.700 333.521USD 9,143,145 -
2025-07-02BUY27,414329.770330.000 329.977USD 9,045,989 -
2025-06-30BUY27,414326.090327.210 327.098USD 8,967,064 -
2025-06-27BUY27,414322.830323.200 323.163USD 8,859,191 -
2025-06-26BUY27,414318.250325.000 324.325USD 8,891,046 -
2025-06-25BUY27,414321.940324.320 324.082USD 8,884,384 -
2025-06-24BUY27,414325.000326.030 325.927USD 8,934,963 -
2025-06-23BUY27,414313.130314.780 314.615USD 8,624,856 -
2025-06-20BUY27,414309.700314.500 314.020USD 8,608,544 -
2025-06-19BUY27,414 312.320* -
2025-06-18BUY27,414312.320317.540 317.018USD 8,690,732 -
2025-06-17BUY27,414308.710309.060 309.025USD 8,471,611 -
2025-06-16BUY27,414308.780309.630 309.545USD 8,485,867 -
2025-06-13BUY27,414307.990308.020 308.017USD 8,443,978 -
2025-06-12BUY27,414304.670307.480 307.199USD 8,421,554 -
2025-06-11BUY27,414298.580303.850 303.323USD 8,315,297 -
2025-06-10BUY27,414302.460308.890 308.247USD 8,450,284 -
2025-06-09BUY27,414304.000306.170 305.953USD 8,387,396 -
2025-06-06BUY27,414300.830310.220 309.281USD 8,478,629 -
2025-06-05BUY27,414308.000308.530 308.477USD 8,456,588 -
2025-06-04BUY27,414305.310308.930 308.568USD 8,459,083 -
2025-06-03BUY27,414303.770307.850 307.442USD 8,428,215 -
2025-06-02BUY27,414306.090307.190 307.080USD 8,418,291 -
2025-05-30BUY27,414304.560306.000 305.856USD 8,384,736 -
2025-05-29BUY27,414292.900293.220 293.188USD 8,037,456 -
2025-05-28BUY27,414285.560291.540 290.942USD 7,975,884 -
2025-05-27BUY27,414290.100295.440 294.906USD 8,084,553 -
2025-05-26BUY27,414 289.960* -
2025-05-23BUY27,414289.960291.220 291.094USD 7,980,051 -
2025-05-22BUY27,414289.000291.540 291.286USD 7,985,315 -
2025-05-21BUY27,414292.580298.230 297.665USD 8,160,189 -
2025-05-20BUY27,414291.680292.990 292.859USD 8,028,436 -
2025-05-19BUY27,414291.860296.800 296.306USD 8,122,932 -
2025-05-16BUY27,414285.310289.750 289.306USD 7,931,035 -
2025-05-15BUY27,414283.400285.000 284.840USD 7,808,604 -
2025-05-14BUY27,414267.550270.000 269.755USD 7,395,064 -
2025-05-13BUY27,414266.860268.070 267.949USD 7,345,554 -
2025-05-12BUY27,414270.190270.200 270.199USD 7,407,236 -
2025-05-09BUY27,414251.150260.000 259.115USD 7,103,379 -
2025-05-08BUY27,414258.350270.000 268.835USD 7,369,843 -
2025-05-07BUY27,414276.550277.850 277.720USD 7,613,416 -
2025-05-06BUY27,414269.810276.470 275.804USD 7,560,891 -
2025-05-05BUY27,414273.550273.970 273.928USD 7,509,462 -
2025-05-02BUY27,414259.390265.000 264.439USD 7,249,331 -
2025-05-01BUY27,414255.130265.910 264.832USD 7,260,105 -
2025-04-30BUY27,414263.240263.680 263.636USD 7,227,317 -
2025-04-29BUY27,414257.190260.540 260.205USD 7,133,260 -
2025-04-28BUY27,414254.850256.570 256.398USD 7,028,895 -
2025-04-25BUY27,414251.560253.250 253.081USD 6,937,963 -
2025-04-24BUY27,414242.610243.690 243.582USD 6,677,557 -
2025-04-23BUY27,414241.970248.590 247.928USD 6,796,698 -
2025-04-22BUY27,414236.750238.630 238.442USD 6,536,649 -
2025-04-21BUY27,414232.750237.770 237.268USD 6,504,465 -
2025-04-18BUY27,414 234.560* -
2025-04-17BUY27,414234.560235.120 235.064USD 6,444,044 -
2025-04-16BUY27,414230.500234.500 234.100USD 6,417,617 -
2025-04-15BUY27,414230.930242.150 241.028USD 6,607,541 -
2025-04-14BUY27,414240.010241.830 241.648USD 6,624,538 -
2025-04-11BUY27,414237.770240.000 239.777USD 6,573,247 -
2025-04-10BUY27,414226.280235.330 234.425USD 6,426,527 -
2025-04-09BUY27,414243.270245.560 245.331USD 6,725,504 -
2025-04-08BUY27,414224.320246.150 243.967USD 6,688,111 -
2025-04-07BUY27,414232.950241.830 240.942USD 6,605,184 -
2025-04-04BUY27,414235.740259.160 256.818USD 7,040,409 -
2025-04-02BUY27,414266.830267.290 267.244USD 7,326,227 -
2025-04-01BUY27,414255.760273.610 271.825USD 7,451,810 -
2025-03-31BUY27,414270.020271.850 271.667USD 7,447,479 -
2025-03-28BUY27,414268.460271.300 271.016USD 7,429,632 -
2025-03-27BUY27,414271.020276.570 276.015USD 7,566,675 -
2025-03-19SELL-51,509253.440255.350 255.159USD -13,142,985 -
2025-03-10BUY130,432233.070244.330 243.204USD 31,721,584 -
2025-03-07BUY120,863244.520251.120 250.460USD 30,271,347 -
2025-02-19BUY51,509250.510254.010 253.660USD 13,065,773 -
2025-02-18BUY8,276250.000260.000 259.000USD 2,143,484 -
2025-02-14BUY8,276256.450264.870 264.028USD 2,185,096 -
2025-02-13BUY8,276264.890268.520 268.157USD 2,219,267 -
2025-02-12BUY8,276265.960268.200 267.976USD 2,217,769 -
2025-02-11BUY8,276268.990273.230 272.806USD 2,257,743 -
2025-02-10BUY8,276274.060276.230 276.013USD 2,284,284 -
2025-02-07BUY8,276276.190278.030 277.846USD 2,299,453 -
2025-02-06BUY8,276278.250279.240 279.141USD 2,310,171 -
2025-02-05BUY8,276276.310278.440 278.227USD 2,302,607 -
2025-02-04BUY8,276271.000277.980 277.282USD 2,294,786 -
2025-02-03BUY8,276274.550278.510 278.114USD 2,301,672 -
2025-01-31BUY8,276271.310279.340 278.537USD 2,305,172 -
2025-01-30BUY8,276277.160279.360 279.140USD 2,310,163 -
2025-01-29BUY8,276273.990279.700 279.129USD 2,310,072 -
2025-01-28BUY8,276279.190283.560 283.123USD 2,343,126 -
2025-01-27BUY8,276276.730287.220 286.171USD 2,368,351 -
2025-01-24BUY8,276278.760279.670 279.579USD 2,313,796 -
2025-01-23BUY8,276275.540277.220 277.052USD 2,292,882 -
2025-01-22SELL-8,276266.540269.140 268.880USD -2,225,251 -
2025-01-21BUY8,276264.990265.020 265.017USD 2,193,281 -
2025-01-20BUY8,276 246.270* -
2025-01-17BUY8,276246.270253.500 252.777USD 2,091,982 -
2025-01-15BUY8,276251.010255.300 254.871USD 2,109,312 -
2025-01-14BUY8,276240.510259.600 257.691USD 2,132,651 -
2025-01-13BUY8,276258.270261.860 261.501USD 2,164,182 -
2025-01-09BUY8,276 240.550* -
2025-01-08BUY8,276240.550240.650 240.640USD 1,991,537 -
2025-01-02BUY8,276233.620239.990 239.353USD 1,980,885 -
2024-12-30BUY8,276236.010236.950 236.856USD 1,960,220 -
2024-12-10BUY8,276253.910257.990 257.582USD 2,131,749 -
2024-12-09BUY8,276255.890258.120 257.897USD 2,134,356 -
2024-12-06BUY8,276256.260257.810 257.655USD 2,132,353 -
2024-12-05BUY8,276251.810255.290 254.942USD 2,109,900 -
2024-12-04BUY8,276254.720256.680 256.484USD 2,122,662 -
2024-12-03BUY8,276251.840253.210 253.073USD 2,094,432 -
2024-12-02BUY8,276253.010255.290 255.062USD 2,110,893 -
2024-11-29BUY8,276253.070254.180 254.069USD 2,102,675 -
2024-11-28BUY8,276 253.740* -
2024-11-27BUY8,276253.740256.020 255.792USD 2,116,935 -
2024-11-26BUY8,276253.350253.740 253.701USD 2,099,630 -
2024-11-21BUY8,276246.800250.710 250.319USD 2,071,640 -
2024-11-20BUY8,276248.790249.100 249.069USD 2,061,295 -
2024-11-19BUY8,276234.270235.940 235.773USD 1,951,257 -
2024-11-12BUY8,276268.950270.770 270.588USD 2,239,386 -
2024-11-11SELL-8,276279.820286.580 285.904USD -2,366,141 -
2024-11-07SELL-8,276272.220275.070 274.785USD -2,274,121 -
2024-10-31SELL-8,276266.590276.000 275.059USD -2,276,388 -
2024-10-30SELL-8,276281.490287.870 287.232USD -2,377,132 -
2024-10-29BUY11,081284.690287.020 286.787USD 3,177,887 -
2024-10-28BUY13,886286.910290.940 290.537USD 4,034,397 -
2024-10-24SELL-13,886293.690301.050 300.314USD -4,170,160 -
2024-10-21SELL-13,886292.010295.390 295.052USD -4,097,092 -
2024-10-18BUY13,886295.930298.940 298.639USD 4,146,901 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALNY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19216,7273,259396,24354.7%
2025-09-18172,875397386,43244.7%
2025-09-17246,547167472,29252.2%
2025-09-1688,84660226,33639.3%
2025-09-15148,25813,572435,68934.0%
2025-09-12134,122300244,96854.8%
2025-09-11219,8687,820411,70253.4%
2025-09-10543,3267,595916,89859.3%
2025-09-09705,54033,7311,550,89945.5%
2025-09-08175,158440388,71545.1%
2025-09-05127,116335311,25240.8%
2025-09-04110,9302,555236,56846.9%
2025-09-03182,3868,982562,92132.4%
2025-09-02132,77014,416358,47637.0%
2025-08-2993,2162,181276,59433.7%
2025-08-2860,1821,254226,86526.5%
2025-08-27277,6671,084440,57763.0%
2025-08-26243,404919447,42154.4%
2025-08-25156,55115,662374,27641.8%
2025-08-22228,5961,309408,15256.0%
2025-08-21123,9962,862248,30049.9%
2025-08-20149,63813,723316,98347.2%
2025-08-19144,3201,143308,39946.8%
2025-08-18371,31834,264525,78670.6%
2025-08-15104,01813,245265,62039.2%
2025-08-14133,2724,443505,52826.4%
2025-08-13183,2711,3901,017,62318.0%
2025-08-12173,0454,046693,01825.0%
2025-08-11239,1997,600451,24853.0%
2025-08-08168,7553,199466,74436.2%
2025-08-07308,8104,452527,39958.6%
2025-08-06202,15112,590548,34936.9%
2025-08-05256,29513,237826,28331.0%
2025-08-04411,11436,303729,94956.3%
2025-08-01350,06060,108764,94345.8%
2025-07-31829,1916,0231,541,01553.8%
2025-07-30533,88514,703942,78856.6%
2025-07-29164,26855384,53742.7%
2025-07-28150,24069571,96526.3%
2025-07-2590,782429298,80130.4%
2025-07-24132,00111,546286,15546.1%
2025-07-23184,14963312,34059.0%
2025-07-22134,7617,553524,61225.7%
2025-07-21113,303101243,11946.6%
2025-07-1884,1179196,31742.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy